Reaction
Alveolar Lung Disease reporting signals
As of the last recalculation, Alveolar Lung Disease appears in 189 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is RIFAMPICIN (PRR 270.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Rifampicin | 22 | 270.9 | 271.5 |
| Cholestyramine | 20 | 203.6 | 203.9 |
| Daptomycin | 15 | 194.4 | 194.7 |
| Linezolid | 26 | 111.4 | 111.5 |
| Piperacillin And Tazobactam | 11 | 100.5 | 100.6 |
| Piperacillin Sodium,Tazobactam Sodium | 16 | 72.5 | 72.5 |
| Rifampin | 9 | 71.2 | 71.3 |
| Lanreotide Acetate | 3 | 42.8 | 42.8 |
| Erlotinib | 3 | 34.6 | 34.6 |